20
Atul Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and WHO-GMP.
One of their notable products is DAPSONE USP, with a corresponding US DMF Number 17781.
Remarkably, this DMF maintains an Active status since its submission on October 28, 2004, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 12, 2013, and payment made on February 26, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II